Nyt fra tidsskrifterne
Søgeord (phase 3) valgt.
13 emner vises.
1
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults who had Previously Received a Meningococcal ACWY Vaccine: Phase 3, Randomized, Controlled Clinical Study
Clinical Infectious Diseases
Tilføjet 26.12.2024
2
The Current and Future State of Vaccines for Lyme Disease
Clinical Infectious Diseases
Tilføjet 23.12.2024
3
SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants
Antimicrobial Agents And Chemotherapy
Tilføjet 20.12.2024
4
Weight and metabolic changes with long-acting cabotegravir and rilpivirine or bictegravir/emtricitabine/tenofovir alafenamide
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 19.12.2024
5
Toward Evidence-based Recommendations for Laboratory Monitoring for Adolescents and Adults on Antiretroviral Therapy
Clinical Infectious Diseases
Tilføjet 11.12.2024
6
[Articles] Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
Lancet Infectious Diseases
Tilføjet 6.12.2024
7
Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: Analysis from a Phase 3 randomized clinical trial (MELODY)
Clinical Infectious Diseases
Tilføjet 5.12.2024
8
Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA)
BMJ Open
Tilføjet 1.12.2024
9
[Articles] Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial
Lancet
Tilføjet 29.11.2024
10
Development of high titer anti-drug antibodies in a Phase 1b/2a infant clesrovimab trial are associated with RSV exposure beyond day 150
Journal of Infectious Diseases
Tilføjet 28.11.2024
11
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
American Journal of Respiratory and Critical Care Medicine
Tilføjet 28.11.2024
12
Non-inferiority study of purified Vero rabies vaccine – serum free in three-dose and two-dose pre-exposure prophylaxis regimens in comparison with licensed rabies vaccines
Clinical Infectious Diseases
Tilføjet 26.11.2024
13
[Articles] Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
Lancet Infectious Diseases
Tilføjet 26.11.2024